Oropharyngeal Human Papilloma Virus (HPV) Infection


What is human papilloma virus (HPV)?

HPV is a sexually transmitted virus. There are more than 150 subtypes of HPV that can infect the genital area and the throat (oropharyngeal HPV).

How common is oropharyngeal human papilloma virus (HPV) infection of the throat?

A recent study found that 7 percent of Americans 14 to 69 years old are infected with oropharyngeal HPV. The same study found that the prevalence has increased significantly over the past three decades, and that more men than women have oropharyngeal HPV infection.

The most frequent subtype of oropharyngeal HPV detected is HPV-16, a high-risk subtype of HPV for oropharyngeal (throat) cancer. About 2/3 of oropharyngeal cancers have HPV DNA in them. Infection with HPV-16 occurs in about 1 percent of men and women.

How is oropharyngeal human papilloma virus (HPV) acquired?

Evidence strongly suggests that oropharyngeal HPV is predominantly transmitted by sexual contact. An increase in oral sex is suspected as the cause of the increase in the prevalence of oropharyngeal HPV infection, although several sexual behaviors seem to be related to HPV prevalence.

The risk of infection increases with an increasing number of lifetime or recent sexual partners for any type of sexual behavior (vaginal sex, oral sex). With 20 or more lifetime sexual partners, the prevalence of oropharyngeal HPV infection reaches 20 percent. Smokers are also at greater risk than nonsmokers, with current heavy smokers at particularly high risk.

Symptoms and Causes

What are the signs and symptoms of oropharyngeal human papilloma virus (HPV) infection?

Most people with oropharyngeal HPV infections have no symptoms and therefore do not realize that they are infected and can transmit the virus to a partner.

What are the consequences of oropharyngeal human papilloma virus (HPV) infection?

Tonsillar HPV infection can cause oropharyngeal cancer. An increase in the incidence of oropharyngeal cancer has paralleled the increased prevalence of tonsillar HPV infection. However, the vast majority of people with tonsillar HPV infections do not develop cancer because the subtypes of HPV with which they are infected are not linked to development of cancer. Although millions of Americans have tonsillar HPV, fewer than 15,000 get HPV-positive oropharyngeal cancers annually.

Some oropharyngeal cancers are not related to HPV infection, but rather with tobacco and alcohol use. People with HPV-positive oropharyngeal cancers tend to be younger and are less likely to be smokers and drinkers.

Are there any signs that are specific for human papilloma virus (HPV)-positive oropharyngeal cancer?

The first sign is often having trouble with swallowing. Other signs are:

  • Coughing up blood
  • A lump on the neck or in the cheek
  • Hoarseness that doesn’t go away

Unfortunately, these are late signs of the disease.

Other potential signs and symptoms of oral cancers are:

  • Sore throat
  • A white or red patch on the tonsils
  • Jaw pain or swelling
  • Trouble swallowing that is new

These signs don’t necessarily mean that you have cancer, but if any signs are present for longer than two weeks, you should see your doctor.

Diagnosis and Tests

How is oropharyngeal human papilloma virus (HPV) infection found?

There is no test that can find early signs of HPV infection of the throat. Some cancerous or precancerous oropharyngeal HPV lesions may be detected during screening or examination by a dentist or doctor, but most are found by testing in persons who already have signs or symptoms.

To inspect hard-to-see areas of the throat, larynx (voice box), and the base of the tongue, doctors may use small mirrors. For certain structures in the throat that can’t be seen easily with mirrors, flexible laryngoscopes and pharyngoscopes can penetrate deeper to permit the doctor to see them directly.

The doctor may want to perform a biopsy of areas that look suspicious for cancer. A biopsy is a small sample of cells taken with a thin, hollow needle or forceps. The cells are then viewed under a microscope to look for signs of cancer. Biopsy samples from throat cancers may be tested for the presence of HPV DNA. The presence of HPV DNA signals a cancer that is more responsive to treatment than one that is HPV-negative.

Management and Treatment

How is an oropharyngeal human papilloma virus (HPV)-positive cancer treated?

The treatment of choice is either chemotherapy or radiation therapy up front, or surgery followed by radiation therapy with or without the addition of chemotherapy. Radiation therapy involves the delivery of high levels of radiation to kill cancer cells or to keep them from growing and dividing. Chemotherapy is a cancer treatment used most often to describe drugs that kill cancer cells and usually given intravenously.

After surgery to remove an oropharyngeal cancer, further surgery may be needed to reconstruct parts of the oral cavity that were removed as part of the treatment.


Can oropharyngeal human papilloma virus (HPV) infection be prevented?

The only surefire way to prevent it is to abstain from sex. Vaccines have been developed that reduce the risk of infection with subtypes of HPV that are known to cause cervical cancer, although their effect in preventing oropharyngeal cancers linked to the same HPV subtypes is unknown. These vaccines are prophylactic vaccines in that they may prevent HPV infection (they do not treat an existing infection), and thus are recommended before a person is sexually active. Several vaccines are now available through your doctor.

The Centers for Disease Control and Prevention (CDC) recommends that all 11- or 12-year-old girls receive the HPV vaccine to protect against cervical cancer, and that females 13 to 26 years old be vaccinated if they have not received the HPV vaccine when they were younger.

The CDC also recommends the HPV vaccine for all boys aged 11 or 12 years, and for males 13 to 21 years old who did not receive the vaccine when they were younger. All men may receive the vaccine through age 26. The HPV vaccine is also recommended for any man who has sex with men and men with compromised immune systems through age 26 (if not vaccinated at a younger age).

Talk to your doctor to find out if getting vaccinated is right for you and which vaccine is best for you.

Outlook / Prognosis

What is the prognosis for human papilloma virus (HPV)-positive oropharyngeal cancer?

Fortunately, HPV-positive oropharyngeal cancers have better outcomes and fewer relapses after treatment than HPV-negative cancers. In patients with oropharyngeal cancer treated with radiation and chemotherapy, survival was longer among those with HPV-positive tumors vs. HPV-negative tumors.

Last reviewed by a Cleveland Clinic medical professional on 09/04/2018.


  • Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
  • Gillison ML, Broutian T, Pickard RKL, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012;307:693-703.
  • Chaturvedi AK, Engles EA, Pfieffer RM, et al. Human papillomavirus and the rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294-4301.
  • American Cancer Society. What's new in oral cavity and oropharyngeal cancer research and treatment? (https://www.cancer.org/cancer/oral-cavity-and-oropharyngeal-cancer/about/new-research.html) Accessed 9/24/2018.
  • Young D, Xiao CC, et al. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). (https://www.ncbi.nlm.nih.gov/pubmed/26066977) Oral Oncol. 2015 Aug; 51 (8): 727-30. Accessed 9/24/2018.

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy